Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMC 96231)

Published in Clin Diagn Lab Immunol on November 01, 2001

Authors

S M Arend1, A C Engelhard, G Groot, K de Boer, P Andersen, T H Ottenhoff, J T van Dissel

Author Affiliations

1: Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. s.m.arend@lumc.nl

Articles citing this

Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol (2005) 2.02

Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One (2008) 1.40

Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection. Infect Immun (2004) 1.30

Comparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol (2006) 1.16

Genomic approach to identification of Mycobacterium bovis diagnostic antigens in cattle. J Clin Microbiol (2003) 1.16

Protein-protein interactions of proteins from the ESAT-6 family of Mycobacterium tuberculosis. J Bacteriol (2004) 1.13

Diagnosis of Mycobacterium tuberculosis infection using ESAT-6 and intracellular cytokine cytometry. Clin Exp Immunol (2005) 1.07

Selected pool of peptides from ESAT-6 and CFP-10 proteins for detection of Mycobacterium tuberculosis infection. J Clin Microbiol (2004) 1.05

ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia. J Clin Microbiol (2005) 1.05

Use of antibodies in lymphocyte secretions for detection of subclinical tuberculosis infection in asymptomatic contacts. Clin Diagn Lab Immunol (2004) 0.93

ESAT-6 and CFP-10: what is the diagnosis? Infect Immun (2002) 0.93

New approaches in the diagnosis and treatment of latent tuberculosis infection. Respir Res (2010) 0.92

Current issues on molecular and immunological diagnosis of tuberculosis. Yonsei Med J (2007) 0.89

Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis. Clin Vaccine Immunol (2009) 0.83

Low agreement between the T-SPOT®.TB assay and the tuberculin skin test among college students in China. Int J Tuberc Lung Dis (2011) 0.79

Tuberculin Skin Test among 1,424 Healthy Employees in Chaharmahal Province, Iran. Tanaffos (2011) 0.78

Latent tuberculosis: revised treatment guidelines. CMAJ (2003) 0.77

Comparison of QuantiFERON-TB gold in tube test versus tuberculin skin test for screening of latent tuberculosis infection in Saudi Arabia: A population-based study. Ann Thorac Med (2016) 0.75

Blood Cells and Interferon-Gamma Levels Correlation in Latent Tuberculosis Infection. ISRN Pulmonol (2013) 0.75

Articles cited by this

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82

Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science (1999) 17.48

Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med (2000) 13.69

Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med (2000) 10.50

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J Bacteriol (1996) 10.26

Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun (1995) 6.43

A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology (1998) 4.97

The tuberculin skin test. Clin Infect Dis (1993) 4.89

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun (1996) 4.68

Adoptive protection of the Mycobacterium tuberculosis-infected lung. Dissociation between cells that passively transfer protective immunity and those that transfer delayed-type hypersensitivity to tuberculin. Cell Immunol (1984) 4.00

Proteins released from Mycobacterium tuberculosis during growth. Infect Immun (1991) 3.69

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis (1999) 3.61

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun (2000) 3.24

Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol (2000) 3.03

Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis (2000) 2.70

The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis (1997) 2.64

Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection. Int J Tuberc Lung Dis (1998) 2.50

Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect Immun (1996) 2.43

Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol (1998) 2.35

Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun (2000) 2.29

Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis. Scand J Immunol (1997) 2.13

Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97

Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun (1991) 1.92

Community-wide implementation of targeted testing for and treatment of latent tuberculosis infection. Clin Infect Dis (1999) 1.75

Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet (1994) 1.73

Has BCG attenuated to impotence? Nature (1997) 1.70

Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69

Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection. Infect Immun (2000) 1.67

Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol (1999) 1.65

Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun (1998) 1.61

The time-table of tuberculosis. Tubercle (1948) 1.60

Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis (2001) 1.56

Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol (1998) 1.49

Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J Infect Dis (1998) 1.43

Identification of an effective vaccine against tuberculosis. Am Rev Respir Dis (1988) 1.34

Bacille Calmette-Guérin vaccinations and tuberculin skin tests. JAMA (1985) 1.33

Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis (2000) 1.20

In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin. Clin Infect Dis (2000) 1.19

T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles. Clin Exp Immunol (1996) 1.14

The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci U S A (1997) 1.12

Some clinical features of tuberculosis. 1. Incubation period. Acta Tuberc Scand (1950) 1.11

Does size matter? Utility of size of tuberculin reactions for the diagnosis of mycobacterial disease. Am J Respir Crit Care Med (2000) 1.10

Tuberculosis screening among immigrants in The Netherlands: what is its contribution to public health? Neth J Med (2000) 1.02

Disease-specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis. J Immunol Methods (1999) 0.98

Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure. J Infect Dis (1999) 0.95

Articles by these authors

7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med (2001) 7.05

Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun (1995) 6.43

Maximal perfusion of skeletal muscle in man. J Physiol (1985) 6.05

T cell response to Mycobacterium tuberculosis. J Infect Dis (1993) 5.53

A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10). Microbiology (1998) 4.97

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun (1996) 4.68

Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science (1999) 4.56

Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science (1998) 4.24

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis (1999) 3.61

Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59

Entorhinal activation of dentate granule cells. Acta Physiol Scand (1966) 3.51

Spatial learning with a minislab in the dorsal hippocampus. Proc Natl Acad Sci U S A (1995) 3.42

Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med (1991) 3.41

Nitric oxide: a predictor of morbidity in postoperative patients? Lancet (1994) 3.26

Unit analysis of hippocampal polulation spikes. Exp Brain Res (1971) 3.24

Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun (2000) 3.24

Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT). BMJ (2010) 3.23

Rise in maternal mortality in the Netherlands. BJOG (2009) 3.15

Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J Neurosci (1993) 3.11

Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol (2000) 3.03

Imaging brain function in humans at 7 Tesla. Magn Reson Med (2001) 2.98

ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun (2000) 2.87

Dynamic knee extension as model for study of isolated exercising muscle in humans. J Appl Physiol (1985) (1985) 2.82

Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol (1996) 2.80

Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-gamma assay. Eur Respir J (2007) 2.80

Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis (2000) 2.70

Capillary supply of the quadriceps femoris muscle of man: adaptive response to exercise. J Physiol (1977) 2.65

The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis (1997) 2.64

Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun (2001) 2.62

Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol (2000) 2.61

Two different responses of hippocampal pyramidal cells to application of gamma-amino butyric acid. J Physiol (1980) 2.59

Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature (1986) 2.59

An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial). BJOG (2010) 2.50

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. Tuber Lung Dis (1999) 2.50

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect (2009) 2.44

Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun (1995) 2.39

Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides. Infect Immun (2000) 2.29

Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runners. Ann N Y Acad Sci (1977) 2.26

Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci U S A (2001) 2.21

Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection. J Infect Dis (2011) 2.21

Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell (1998) 2.21

In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med (2001) 2.12

An increase in dendritic spine density on hippocampal CA1 pyramidal cells following spatial learning in adult rats suggests the formation of new synapses. Proc Natl Acad Sci U S A (1994) 2.06

High contrast and fast three-dimensional magnetic resonance imaging at high fields. Magn Reson Med (1995) 2.06

Adjuvant modulation of immune responses to tuberculosis subunit vaccines. Infect Immun (1997) 2.05

Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle. Infect Immun (1997) 2.05

Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis (2001) 2.02

Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent. Protein Expr Purif (2000) 2.00

Lamellar organization of hippocampal pathways. Exp Brain Res (1971) 1.99

Specific long-lasting potentiation of synaptic transmission in hippocampal slices. Nature (1977) 1.98

Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol (1999) 1.97

Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens. Clin Diagn Lab Immunol (1999) 1.94

Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium. J Immunol (1987) 1.92

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med (2001) 1.89

B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis. Infect Immun (1998) 1.86

Low-field magnetic resonance imaging of the lumbar spine: reliability of qualitative evaluation of disc and muscle parameters. Acta Radiol (2006) 1.83

Capillary density in skeletal muscle of man. Acta Physiol Scand (1975) 1.82

Detunable transverse electromagnetic (TEM) volume coil for high-field NMR. Magn Reson Med (2002) 1.80

Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature (1994) 1.79

Possible mechanisms for long-lasting potentiation of synaptic transmission in hippocampal slices from guinea-pigs. J Physiol (1980) 1.76

Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in The Gambia. Infect Immun (2001) 1.74

Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection. Electrophoresis (2000) 1.74

Guinea pig cellular immune responses to proteins secreted by Mycobacterium tuberculosis. Infect Immun (1995) 1.72

Structure and function of a 40,000-molecular-weight protein antigen of Mycobacterium tuberculosis. Infect Immun (1992) 1.69

Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature (1986) 1.69

Detection of respiratory syncytial virus in nasopharyngeal secretions by ELISA: comparison with fluorescent antibody technique. J Med Virol (1982) 1.65

Treatment-related chromosome abnormalities in human embryos. Hum Reprod (1997) 1.65

Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol (1999) 1.65

Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin. J Immunol (1997) 1.64

Antibody response to influenza, tetanus and pneumococcal vaccines in HIV-seropositive individuals in relation to the number of CD4+ lymphocytes. AIDS (1994) 1.61

Delayed-type hypersensitivity responses to ESAT-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig. Infect Immun (1998) 1.61

Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect Immun (2001) 1.60

Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol (1997) 1.60

Molecular and immunological analysis of a fibronectin-binding protein antigen secreted by Mycobacterium leprae. Mol Microbiol (1992) 1.59

HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol (1997) 1.57

Use of ESAT-6 and CFP-10 antigens for diagnosis of extrapulmonary tuberculosis. J Infect Dis (2001) 1.56

Functional characteristics of unmyelinated fibres in the hippocampal cortex. Brain Res (1978) 1.54

Assessment of defined antigens for the diagnosis of bovine tuberculosis in skin test-reactor cattle. Vet Rec (2000) 1.54

A comparison of distal and proximal dendritic synapses on CAi pyramids in guinea-pig hippocampal slices in vitro. J Physiol (1980) 1.52

Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol (1996) 1.52

Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob Agents Chemother (1998) 1.50

Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis. Scand J Immunol (1998) 1.49

Good's syndrome: the association of thymoma and hypogammaglobulinemia. Clin Infect Dis (2001) 1.49

Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol (2000) 1.48

Early antibody responses to experimental Mycobacterium bovis infection of cattle. Clin Vaccine Immunol (2006) 1.48

Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis (2010) 1.48

Association between brain temperature and dentate field potentials in exploring and swimming rats. Science (1993) 1.47

[Predictive value of chills in patients presenting with fever to urgent care department]. Ned Tijdschr Geneeskd (2002) 1.44

Smooth-muscle antibodies and other tissue antibodies in cytomegalovirus infection. Clin Exp Immunol (1975) 1.44

Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet (1986) 1.43

Synaptic efficacy and EPSP summation in granule cells of rat fascia dentata studied in vitro. J Neurophysiol (1981) 1.42

Unsteady flow through in-vitro models of the glottis. J Acoust Soc Am (2003) 1.41

Towards the proteome of Mycobacterium tuberculosis. Electrophoresis (2000) 1.39

The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2. J Exp Med (1989) 1.39